Fagron Concepts

Looking at expanding or starting up compounding in your pharmacy? Fagron can assist you in furnishing your lab in compliance with the Pharmacy Board Compounding Guidelines
SyrSpend™ SF is an innovative vehicle range for preparing oral liquid dosage forms. The excellent compatibility with a broad range of medications and meticulous ingredient safety make SyrSpend™ SF vital for every compounding pharmacist.
Fagron Advanced Derma is the revolutionary global standard for advanced skin care. It offers pharmaceutical bases that are formulated according to the latest scientific knowledge

News

Friday, November 16, 2018
Fagron Australia Passes ISO 9001:2015 Certification Audit
Wednesday, September 26, 2018
The Pharmacy Council of NSW have recently updated their Fact Sheet and FAQs based on the feedback received from the industry.
Thursday, July 5, 2018
Knowing when it is suitable for crushing commercial products for a suspension is crucial for ensuring the formulation remains uniform and stable.

News archive

Friday, November 16, 2018
Fagron Australia Passes ISO 9001:2015 Certification Audit
Wednesday, September 26, 2018
The Pharmacy Council of NSW have recently updated their Fact Sheet and FAQs based on the feedback received from the industry.
Thursday, July 5, 2018
Knowing when it is suitable for crushing commercial products for a suspension is crucial for ensuring the formulation remains uniform and stable.
Thursday, April 12, 2018
Versatile™ is the only cream base proven to provide simultaneous percutaneous absorption of six commonly prescribed pain drugs while remaining durable and elegant.
Wednesday, March 28, 2018
Increase your compounding knowledge while earning CPD points on our course at the AJP.
Friday, June 9, 2017
New research reveals the benefits of SyrSpend® SF PH4 stability with active ingredients of various pharmaceutical classes
Tuesday, April 4, 2017
A new published article in the International Journal of Pharmaceutical Compounding discusses suspensions as a valuable alternative for compounded capsules with respect to content uniformity. 
Thursday, January 12, 2017
The use of parabens is associated with certain health-risks in humans and should be avoided whenever possible as stated in guidelines by the European Medicines Agency (EMA).
Friday, December 16, 2016
The team at Fagron Compounding Supplies Australia wishes you happy holidays and a wonderful 2017!
Friday, December 9, 2016
A new peer-reviewed study, published in the European Journal of Hospital Pharmacy, demonstrated the compatibility of several proton pump inhibitors (PPIs) in SyrSpend® SF Alka. SyrSpend® SF Alka.
Monday, November 14, 2016
The US FDA issued the final rule in September, establishing that over-the-counter (OTC) consumer antiseptic wash products can no longer contain certain ingredients, including triclosan.
Friday, September 9, 2016
Following the public consultation on the use of methylisothiazolinone (MI), the European Commission (EC) now announced the ban for the use of MI in leave-on products as of 12 February 2017.
Thursday, September 8, 2016
Pentravan® and Pentravan® Plus are oil-in-water emulsion bases that uses liposomal technology for effective transdermal drug delivery.
Thursday, July 14, 2016
Although the influenza activity remains at low levels in Australia, an increase in activity has recently been observed in some areas. Outbreaks of influenza can create a higher demand for oseltamivir, particularly in the oral liquid dose form.
Friday, July 1, 2016
Fagron is happy to announce that SyrSpend® SF is currently being recognized by large pharmaceutical companies for its quality and compatibility, as is demonstrated by the fact that two big pharmaceutical companies are using the product for their clinical
Monday, May 30, 2016
Fagron carries all ingredients to compound mupirocin 2% ointment and cream. Our Occluvan™ anhydrous ointment base is an ideal vehicle to prepare the mupirocin ointment, as it's easily spreadable and has a skin-friendly formulation.
Thursday, April 14, 2016
In a study published in the April edition of Die Pharmazie, the physical and chemical stability of 10 APIs was studied in SyrSpend® SF PH4 liquid
Tuesday, March 22, 2016
With SyrSpend® SF, Fagron is creating the world's largest compatibility library for a single oral liquid vehicle. A new article has recently been published in the International Journal of Pharmaceutical Compounding (IJPC).
Monday, March 7, 2016
Medication for children is frequently not commercially available.The majority of children can't swallow tablets or capsules until the age of six. In many cases, an oral liquid dosage form is a suitable alternative. However, when reviewing some formulation
Monday, February 15, 2016
Serious health risks are associated with exposure to hormones and other powders involved in pharmaceutical compounding. Here at Fagron we carry three sizes of powder containment hoods to minimise your staff's exposure to harmful chemicals. 
Tuesday, February 2, 2016
For the entire month we will be highlighting our range of high-quality compounding equipment. With the new year in full swing, it's a good time to assure yourself that your compounding lab has the best equipment suited to your unique setting, providing...
Monday, December 21, 2015
The team at Fagron Compounding Supplies Australia wishes you happy holidays and a wonderful 2016! Fagron will remain open on all business days except for public holidays.
Friday, November 27, 2015
A new article has recently been published in the high-impact Journal of Pharmaceutical and Biomedical Analysis. This article discusses the stability of the following 10 drugs, from a variety of pharmacological classes, in SyrSpend® SF.
Wednesday, November 4, 2015
Progesterone is available in two forms, Progesterone Micronised and Progesterone Wettable.  
Tuesday, October 27, 2015
Fagron has started to study the stability of more than 100 commonly used active pharmaceutical ingredients (APIs) in SyrSpend® SF. The first results of these studies were published this month in the International Journal of Pharmaceutical Compounding.
Wednesday, October 7, 2015
Fagron has your solution for compounding omeprazole suspensions.
Tuesday, September 15, 2015
This September we are celebrating World Pharmacists Day (25/9).
Monday, July 27, 2015
SyrSpend® SF, Fagron's gluten-, sugar-, alcohol-free suspending vehicle with Active Suspending Technology, is the preferred suspending vehicle for many pharmacists, because of the ingredient safety and excellent compatibility with active ingredients.
Tuesday, July 21, 2015
According to a recent study* performed in five community pharmacies in Brisbane, 16.5% of the population experiences swallowing difficulties, often without informing their pharmacist or GP.
Thursday, May 21, 2015
In response to many requests, Fagron offers over 40 different nutritionals, ranging from Arginine to Zinc Picolinate.
Friday, April 17, 2015
Excipients are essential ingredients of almost any dermatological product and required to assure numerous properties of the final preparation, such as spreadability, solubility and stability. Perspectives about the safety and tolerance of ingredients in d
Wednesday, April 1, 2015
Almost 200 new compounding instructions for more than 120 different active pharmaceutical ingredients (APIs) have been added to Compounding Matters. Compounding Matters is Fagron’s free and easy accessible formulations database.
Tuesday, March 24, 2015
Fagron now introduces Vitamin D3 100,000 IU/g to accomodate high-dose vitamin D3 supplementation.
Thursday, February 26, 2015
Fagron Australia hosted its second successful webinar on 25 February. Do you want to watch it again or did you miss it?
Friday, February 6, 2015
Following a succesful first webinar on oral suspensions, Fagron Academy Australia proudly announces its second webinar. On February 25, 2015 Fagron professionals will be discussing the latest innovations in pharmaceutical compounding.
Wednesday, December 10, 2014
A recent randomised, double-blind, placebo controlled study compared treatment with a combination of multiple APIs in Versatile™ to Versatile™ alone in patients with peripheral neuropathy.
Wednesday, November 19, 2014
Fagron Australia proudly launches Fagron Advanced Derma! The product line is a total solution for dermatological and cosmeceutical compounding with excellent stability and optimal ingredient safety.
Wednesday, November 12, 2014
Fagron not only sells top-of-the-line bases, vehicles, and chemicals but also the highest quality equipment and supplies. Fagron carries everything from
Tuesday, November 4, 2014
Fagron Australia is proud to invite you to Australia's very first Fagron Academy event. Fagron professionals will be hosting a free webinar to inform you about the latest developments in compounding oral suspensions.
Thursday, October 30, 2014
More than 200,000 customers worldwide have access to over 5,000 high-quality pharmaceutical raw materials, vehicles and Fagron trademark products, thanks to Fagron’s superior global quality system.
Thursday, October 16, 2014
Do you have access to Fagron Compounding Matters database? This formulation database contains an extensive list of compounding formulations
Thursday, September 25, 2014
On 25 September the world pays attention to the role of the pharmacist in improving health in every corner of the world. This years’ theme is:
Tuesday, August 19, 2014
There is an increasing interest for Pentravan® transdermal cream in scientific literature(1-4). A new publication in the most recent edition of the International Journal of Pharmaceutical Compounding concludes that human female sexual hormones
Thursday, July 10, 2014
With the global launch of SyrSpend® SF Fagron introduces an unparalleled vehicle range for compounding oral liquid medication, based on the latest scientific insights.